Climate of Innovation
Knauer has been awarded second place in a list of the Top 100 Most Innovative Firms in Germany and placed first in the Climate of Innovation category.
Knauer has been awarded second place in a list of the Top 100 Most Innovative Firms in Germany and placed first in the Climate of Innovation category. According to the company, this is the result of a resourceful workforce and the management’s initiative to create an atmosphere conducive to innovation.
The senior management team around managing director Dr Alexander Bünz and owner Alexandra Knauer claims to have identified communication and cooperation as key factors driving the company’s success and generating a constant flow of ideas. The company reports that the 104 employees submit an average of twelve suggestions for improvements each per year, 80% of which are implemented.
The company also puts these principles of communication and cooperation into practice in an unorthodox way; including team-building cooking sessions, where an interdepartmental team tries its hand at roasting, frying and blanching for its co-workers. A system of job rotation provides employees with better insight into their company and the company claims that flat hierarchies and an open-door policy also nurture the climate of innovation.
Further information on the company, the other 99 prize-winning firms and the Top 100 project can be found at www.knauer.net and www.top100.de
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
